These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 29952529

  • 1. Combined use of an ACE-inhibitor and spironolactone in patients with heart insufficiency.
    Schröder J, Goltz L, Knoth H.
    Med Monatsschr Pharm; 2017 Jan; 40(1):24-6. PubMed ID: 29952529
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effectiveness of spironolactone added to an angiotensin-converting enzyme inhibitor and a loop diuretic for severe chronic congestive heart failure (the Randomized Aldactone Evaluation Study [RALES]).
    Am J Cardiol; 1996 Oct 15; 78(8):902-7. PubMed ID: 8888663
    [Abstract] [Full Text] [Related]

  • 5. Aldosterone antagonism in addition to angiotensin-converting enzyme inhibitors in heart failure.
    Bauersachs J, Fraccarollo D.
    Minerva Cardioangiol; 2003 Apr 15; 51(2):155-64. PubMed ID: 12783071
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Dangerous hyperkalemia as sequelae of new treatment strategies of heart failure].
    Fuster D, Frey FJ, Ferrari P.
    Praxis (Bern 1994); 2000 Dec 07; 89(49):2073-6. PubMed ID: 11190849
    [Abstract] [Full Text] [Related]

  • 9. Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study.
    Juurlink DN, Mamdani MM, Lee DS, Kopp A, Austin PC, Laupacis A, Redelmeier DA.
    N Engl J Med; 2004 Aug 05; 351(6):543-51. PubMed ID: 15295047
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Elderly heart failure patients with drug-induced serious hyperkalemia.
    Vanpee D, Swine CH.
    Aging (Milano); 2000 Aug 05; 12(4):315-9. PubMed ID: 11073352
    [Abstract] [Full Text] [Related]

  • 13. Spironolactone in severe heart failure: enhances efficacy of diuretic + ACE inhibitor combinations.
    Prescrire Int; 2000 Oct 05; 9(49):158-9. PubMed ID: 11603418
    [Abstract] [Full Text] [Related]

  • 14. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.
    Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J.
    N Engl J Med; 1999 Sep 02; 341(10):709-17. PubMed ID: 10471456
    [Abstract] [Full Text] [Related]

  • 15. Spironolactone for heart failure.
    Med Lett Drugs Ther; 1999 Sep 10; 41(1061):81-2. PubMed ID: 10505071
    [No Abstract] [Full Text] [Related]

  • 16. Hyperkalaemia in congestive heart failure patients using ACE inhibitors and spironolactone.
    Cruz CS, Cruz AA, Marcílio de Souza CA.
    Nephrol Dial Transplant; 2003 Sep 10; 18(9):1814-9. PubMed ID: 12937229
    [Abstract] [Full Text] [Related]

  • 17. Hyperkalemia in ambulant postcardiac surgery patients during combined therapy with angiotensin-converting enzyme inhibitor, spironolactone, and diet rich in potassium: A report of two cases and review of literature.
    Dixit A, Majumdar G, Tewari P.
    Ann Card Anaesth; 2019 Sep 10; 22(2):162-168. PubMed ID: 30971598
    [Abstract] [Full Text] [Related]

  • 18. Life-threatening hyperkalemia during combined therapy with angiotensin-converting enzyme inhibitors and spironolactone: an analysis of 25 cases.
    Schepkens H, Vanholder R, Billiouw JM, Lameire N.
    Am J Med; 2001 Apr 15; 110(6):438-41. PubMed ID: 11331054
    [Abstract] [Full Text] [Related]

  • 19. New strategies for treatment of heart failure with aldosterone antagonists and the risk of hyperkalaemia.
    Cruz CS, Cruz LS, Domingues GS, Souza CA.
    Expert Opin Drug Saf; 2005 Jul 15; 4(4):677-88. PubMed ID: 16011447
    [Abstract] [Full Text] [Related]

  • 20. The safety of spironolactone treatment in patients with heart failure.
    Anton C, Cox AR, Watson RD, Ferner RE.
    J Clin Pharm Ther; 2003 Aug 15; 28(4):285-7. PubMed ID: 12911680
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.